News
Psoriasis can affect the nails, causing them to become pitted, discolored, and even detached from the nail bed. This type of psoriasis, known as nail psoriasis, can be challenging to treat and may ...
IL-17 inhibitors secukinumab and brodalumab demonstrate similar efficacy in patients with psoriasis for up to a year after ...
Key findings of subgroup analyses included an observed increased psoriasis risk in patients without atopic comorbidities (HR 1.42, 95% CI 1.06-1.89) and those with pretreatment immunoglobulin E (IgE) ...
Most people develop psoriasis symptoms on their skin before they develop signs of PsA, though others notice arthritis symptoms first. People with PsA often have symptoms that affect their nails. In ...
The pathogenesis of tendinopathy and the primary biological change in the tendon that precipitates pathology have generated several pathoaetiological models in the literature. The continuum model of ...
Background: Psoriasis is a chronic inflammatory skin disease that often progresses with nail alterations. It is suspected that there is a correlation between nail psoriasis and enthesitis of the ...
Riboflavin has a protective effect on psoriasis, as increased intake of riboflavin was associated with a reduced risk of developing psoriasis among adults. Higher intake of riboflavin (vitamin B2) may ...
Melanonychia, also known as a dark or black line on the nail, causes a streak of dark pigmentation that runs along the nail bed. It can be a normal color variation, especially in people with ...
If you have psoriasis, you may feel like this autoimmune disease is plenty to cope with all on its own. But unfortunately there are a number of other health issues linked to the condition.
We’re on the precipice of sandal weather, whether your toes are ready or not. But if a particularly persistent and unsightly toenail fungus is giving you some trepidation, here is one powerful $ ...
Alumis Inc. has announced the successful completion of patient enrollment in its pivotal Phase 3 ONWARD clinical program for ESK-001, a treatment for moderate-to-severe plaque psoriasis ...
Researchers conducted a systematic review of 14 studies that included 169 patients (mean age, 46.8 years; 74% women) with psoriasis who underwent MBS. Participants underwent various surgical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results